Table 2 Patients with BCR-ABL1 mutations... | American Society of Hematology

Table 2

Patients with BCR-ABL1 mutations

Patient no.	Mutation	Disease stage	TKI in use at time of mutation detection
1	T315I	AP	Imatinib
2	M244V	AP	Imatinib
3	E459K	AP	Imatinib
4	A433T	AP	Imatinib
5	T315I	CP	Imatinib
6	F317L	AP	Imatinib
7	Y253H	BP	Imatinib
8	Q252H	BP	Imatinib
9	T315I	BP	Imatinib
10	E255V/K	BP	Nilotinib
11	Q252K	AP	Imatinib
12	E255K	BP	Nilotinib
13	F359C	BP	Nilotinib
14	F317L	BP	Dasatinib
15	Y253H	CP	Imatinib
16	E459K	BP	Imatinib
17	G250E	BP	Imatinib
17	F359C	BP	Nilotinib
18	E255K	BP	Imatinib
19	T315I	BP	Imatinib
19	E255K	BP	Dasatinib

Patient no.	Mutation	Disease stage	TKI in use at time of mutation detection
1	T315I	AP	Imatinib
2	M244V	AP	Imatinib
3	E459K	AP	Imatinib
4	A433T	AP	Imatinib
5	T315I	CP	Imatinib
6	F317L	AP	Imatinib
7	Y253H	BP	Imatinib
8	Q252H	BP	Imatinib
9	T315I	BP	Imatinib
10	E255V/K	BP	Nilotinib
11	Q252K	AP	Imatinib
12	E255K	BP	Nilotinib
13	F359C	BP	Nilotinib
14	F317L	BP	Dasatinib
15	Y253H	CP	Imatinib
16	E459K	BP	Imatinib
17	G250E	BP	Imatinib
17	F359C	BP	Nilotinib
18	E255K	BP	Imatinib
19	T315I	BP	Imatinib
19	E255K	BP	Dasatinib